Ideas to action: independent research for global prosperity
Learning from the Pandemic: Making the Most of Genomic Surveillance in Low- and Middle-Income Countries
November 15, 2023
During the COVID-19 pandemic, whole genomic sequencing (WGS)-based surveillance played a key role in identifying variants of concern, investigating their spread and transmissibility, and facilitating the design and optimization of medical countermeasures, including diagnostic tools and vaccines. How...
How Big Is the Risk of Epidemics, Really?
November 13, 2023
The COVID-19 pandemic caused losses of lives and livelihoods on a scale that many of us had never seen in our lifetimes, shedding light on the ways that pandemics are a “neglected dimension” of global security. And yet, as we are already observing, proposals for increased, sustained support for surv...
Estimated Future Mortality from Pathogens of Epidemic and Pandemic Potential
November 13, 2023
Epidemics and pandemics pose a sporadic and sometimes severe threat to human health. How should policymakers prioritize preventing and preparing for such events, relative to other needs? Our simulations suggest that an event having the mortality level of COVID-19 should not be considered a “once in ...
Country Transition Projections up to 2040: Gavi, the Global Fund, and the World Bank’s IDA
October 11, 2023
Many countries are facing a much harsher budgetary prospect than a few years ago. For low- and middle-income countries in particular, domestic health expenditure is expected to plateau or contract (in real terms) for many until 2027, development assistance for health has already plateaued, and a deb...
Will Countries Still Transition from Gavi, the Global Fund, and the World Bank (IDA) in the Post-COVID Era?
October 11, 2023
Prior to the COVID-19 pandemic there were periods of sustained growth in many low- and middle-income countries that led to some optimism about countries “transitioning” from (i.e. no longer being eligible for) support from the major global health financing mechanisms, such as the Global Fund, Gavi, ...
Five Proposals for a New Era in UK Global Health Policy
September 27, 2023
The UK is, hopefully, coming out of its nadir in international development. This is marked by planned rises in development spend, an ambitious new international development white paper, a supportive Minister, and a new parliament in 2024. But before considering any proposal, future governments with ...
Six Recommendations to Improve the Market for Antimicrobials
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...
A New Grand Bargain to Improve the Antimicrobial Market for Human Health
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
The African Union in the G20: Implications for Health Financing in Africa
September 19, 2023
Health systems in Africa are under considerable strain: rapid demographic change, rising non-communicable diseases, and emerging and re-emerging threats such as COVID-19 and Ebola are increasing demands on limited health services. The African Union’s admission to the G20 provides an opportunity for ...
Data Is Essential to Navigating an Era of Pandemics
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...